Share | RSS | Widgets | Home

[-]  12-07-18 23:09

Nohla Therapeutics raises another $11M to support leukemia treatment trials
Seattle startup Nohla Therapeutics has reeled in another $11 million to further develop its leukemia treatment. The spinout of Seattle’s Fred Hutchinson Cancer Research Center is developing a novel stem cell treatment for leukemia that uses cells from donated umbilical cord blood. It could be more effective than traditional bone marrow transplants. In May the company released results from a study that showed 86 percent of patients (13 out of 15) surviving the disease and remaining cancer...

Read the full article on GeekWire »
Facebook TwitterGoogle+

« Back to Feedjunkie.com